Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Health Canada issues advisories over intranasal desmopressin risk

    • 12 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Apotex Inc.Association of increased risk of hyponatremia/water intoxication with all intra-nasal spray formulations of the antidiuretic drug desmopressin (inluding Apo-Desmopressin Spray). Internet Document: [2 pages], 31 Jul 2008. Available from: URL: http://www.hc-sc.gc.ca

    2. 2.

      Apotex Inc.Association of increased risk of hyponatremia/water intoxication with all intranasal spray formulations of the antidiuretic drug desmopressin, including Apo-Desmopressin Spray. Internet Document: [2 pages], 31 Jul 2008. Available from: URL: http://www.hc-sc.gc.ca

    3. 3.

      Apotex Inc.Desmopressin nasal sprays, (including Apo-Desmopressin Spray), are associated with an increased risk of serious side effects involving water retention and decreased blood sodium levels (hyponatremia). Internet Document: [2 pages], 31 Jul 2008. Available from: URL: http://www.hc-sc.gc.ca

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Health Canada issues advisories over intranasal desmopressin risk. React. Wkly. 1215, 2 (2008). https://doi.org/10.2165/00128415-200812150-00004

    Download citation

    Keywords

    • Healthcare Professional
    • Fluid Intake
    • Desmopressin
    • Safety Information
    • Ongoing Treatment